Clinical Research Recruiting Agencies: People for the Study or in It
In a 2024 survey of 852 research sites, 46% said their top challenges, including recruitment and retention (36%) and site staffing (31%), restrict how many new studies they can take on [1]. A shortfall can therefore mean too few patients or too few people to work them, so "recruiting" covers two purchases: people for the study (staffing) and people in it (patient recruitment). Open roles point to a staffing agency, too few eligible referrals to a patient recruitment agency, and a gap in both with no one managing the study to a CRO. Refero does not run recruitment campaigns. We vet and match the clinical research marketing agencies that do, so what follows is written for the buyer, from what those vendors need and see.
Clinical research recruiting agencies at a glance
Both kinds of agency hand the decisive work to the study site, so most of the evidence on what goes wrong sits at that handoff.
- 46% of 852 surveyed research sites said their top challenges restrict how many new studies they can take on [1]
- Across six rare disease studies, 3 of 136 leads who agreed to site contact enrolled, so 97.8% of leads dropped off [2]
- None of the roughly dozen patient recruitment vendors in one 2026 comparison publishes list pricing, and quotes come in five structures [3]
- Financial incentives raised enrollment in 1 of 2 randomized trials [4]
- Late development trial dropout averaged 19.1% in 2019, up from 15.3% in 2012 [5]
Clinical Research Recruiting Agencies: Staffing vs Patient Recruitment
Staffing agencies recruit people to work on a study, and patient recruitment agencies recruit people to take part in it, which makes the first a hiring decision and the second an enrollment decision. That split between people for the study and people in the study decides who buys the service, what gets measured and where the vendor's responsibility ends.
Staffing agencies and patient recruitment agencies compared on the points a study team weighs before briefing either. Cost per patient and per delay day sits in sourced recruitment cost benchmarks.
The "Where its job ends" row matters most, because that is where the two get confused. A staffing agency's work ends when a qualified person is on the delegation log and trained to the protocol, so the placed coordinator still has to find patients through the site's own channels or through referrals from a patient recruitment agency. A patient recruitment agency's work ends at referral, which means even a well-run campaign depends on site staff being available to call, screen and consent the people it sends. Each kind of agency therefore feeds the other's bottleneck, so a study team that buys one without checking the other's constraint can pay for outreach that nobody has time to work.
What a Clinical Research Staffing Agency Does for a Study Team
A clinical research staffing agency places CRAs, CRCs, research nurses and trial managers, and the study team picks among four hire types by how long the gap will last and how much management it wants to keep. Contract placements cover a defined stretch such as a study start-up or a coordinator's leave. Contract-to-hire lets the team test a person before committing, and permanent placement fills a standing vacancy. A functional service provider (FSP) arrangement hands a defined function, such as monitoring, to a managed team that the vendor supervises.
The buyer checks whether the placed person can work on the study quickly. That means GCP experience, familiarity with the therapeutic area and time to protocol training, because a coordinator can only screen or consent patients once the investigator has delegated those tasks to them and they are trained to the protocol [7]. From the vendor side, the question that separates candidates is therefore how soon someone can be delegated and trained, and a polished profile says little about that.
A staffing agency does not find patients, yet placed coordinators are often the people who work patient referrals at the site, which is why staffing can solve what looks like an enrollment problem.
What a Patient Recruitment Agency Does, and Where Its Job Stops
A patient recruitment agency runs outreach, prescreening and referral to sites, and its job stops at the handoff, because consent and eligibility decisions stay with the investigator and delegated site staff [7][9]. The work starts with advertising, and FDA guidance says recruitment advertisements should be reviewed and approved by the IRB as part of the initial review package [10]. That makes IRB submission, revisions and time to approval worth asking about when comparing quotes. For enrollment benchmarks and the recruitment strategies that have evidence behind them, the hub guide to patient recruitment covers the research.
The handoff after a referral shows who owns each step:
- Agency: outreach and prescreening produce a referral.
- Site: staff contact the patient.
- Site: staff screen the patient against the protocol.
- Site: the investigator or delegated staff obtain consent.
- Site and sponsor: the patient is randomized.
Only the first step belongs to the agency, so a "pre-screened pool of patients" is not enrollment. In one rare disease recruitment analysis covering six studies, 136 people screened positive and agreed to site contact, yet only 3 enrolled, a drop-off of 97.8% after lead generation [2]. The setting was narrow (rare disease, social media outreach), so the rate will differ elsewhere, but it shows that the leak sits between the referral and the site's follow-up, which is why the useful question for an agency is who contacts the patient after referral and how fast.
Participant pay is not an agency lever, because the study team proposes it and the IRB reviews its amount, method and timing so that it is neither coercive nor unduly influential; FDA treats it as a recruitment incentive [11]. Participant pay can move enrollment, as it did in one of two randomized trials and did not in the other [4], so it is a study-design decision. This section describes regulator guidance and is not legal advice; confirm with regulatory counsel and the IRB of record.
Where CROs Fit Between Staffing and Patient Recruitment
A contract research organization (CRO) runs trial operations for a sponsor and can bundle staffing and patient recruitment or subcontract either one, so it suits a sponsor that lacks trial management capacity as well as extra hands or extra patients. An industry guide to recruitment companies draws the same line: a recruitment specialist does the narrower job, while a CRO's role is broader and can combine monitoring, data management and regulatory work with recruitment [6]. When a CRO subcontracts patient recruitment, the sponsor is still buying the same service at one remove, so the six vendor types and contract checks apply to the subcontractor as much as to a direct hire.
A list of the top clinical trial companies is a list of the largest CROs by revenue and trial volume, a different category from recruiting agencies, so none is recommended here.
How to Tell Which Clinical Research Recruiting Agency Your Study Needs
A study's symptoms point to the kind of agency it needs: open roles point to staffing, too few eligible referrals point to patient recruitment, and both together with no one managing the study point to a CRO or FSP model.
Choose a staffing agency when roles are open or coordinators keep leaving
Use this when a site cannot start, or has lost the people who would work its patients. A site that lost both coordinators has a people gap, so more outreach would only add referrals nobody can call. Brief the agency on the roles, GCP requirements, therapeutic area and start date, and ask whether the people it places can be on the delegation log and trained to the protocol right away.
Choose a patient recruitment agency when too few interested, eligible referrals arrive
Use this when sites have the staff but the referrals are not coming, for example a hypothetical study at 40% of target enrollment at month six where coordinators report empty waiting lists. Ask what happens after a referral is delivered and who contacts the patient. Ask about retention too, since dropout in late development studies averaged 19.1% in 2019 against 15.3% in 2012 [5], which means a referral count says little about how many patients are still enrolled at the end.
Fix site capacity before buying more outreach when referrals go uncalled
Use this when the funnel shows referrals arriving but sites not calling them back. The shortfall is then a staffing problem, so the staffing agency is the right purchase, because extra patient recruitment spend only lengthens the queue at a site with no coordinator time.
Choose a CRO or FSP model when both gaps appear and no one manages the study
Use this when roles are open, referrals are thin and the sponsor has no capacity to run either fix. A CRO or FSP can own the trial management as well as the hiring or recruitment, so ask which activities it performs itself and which it subcontracts.
Take the next step for your kind of agency
Patient recruitment buyers can shortlist firms from the ranked list of vetted patient recruitment agencies, which sets out how each was assessed. Staffing buyers should write the brief first (roles, GCP needs, start date) and compare placement terms. Job seekers who landed here will find this page written for study teams hiring help; CRC and CRA candidates should go to life sciences recruiters or employers directly, and legitimate placement firms do not charge candidates a fee [8].
If you would rather not run that evaluation alone, Refero screens healthcare marketing and patient recruitment agencies against five published criteria and introduces up to three that fit your brief. It is free for buyers, and there is no obligation to hire anyone we introduce. Tell us what you need.
Frequently asked questions
How do I choose a clinical research recruiting agency?
Decide first whether the gap is people to work the study (staffing), patients to enroll (patient recruitment) or trial management (a CRO). For patient recruitment, shortlist from Refero's vetted list. For staffing, check GCP experience, delegation-log readiness and time to protocol training.
Do clinical research recruiting agencies help job seekers or study teams?
Both readings exist: staffing agencies place candidates with employers, while this page serves study teams. Honest placement firms do not charge job candidates a fee, because the hiring company pays it [8]. Candidates should look to life sciences recruiters or employers directly.
Do participants get paid for clinical research?
Often, as payment or reimbursement that the study team proposes and the IRB reviews so it is neither coercive nor unduly influential [11]. Practice is inconsistent and thinly evidenced, and DIA calls compensation critical yet inconsistently applied [12], so amounts vary by study and none is quoted here.
Is a CRO the same as a clinical research recruiting agency?
No. A CRO runs trial operations and may include or subcontract staffing and patient recruitment [6]. A sponsor picks one over a standalone agency when it also needs trial management, while a sponsor with a single clear gap, such as lost coordinators or thin referrals, is usually better served by the specialist for that gap.
Can a patient recruitment agency consent patients?
No. Informed consent is conducted by the investigator or site staff the investigator has delegated, and the investigator remains responsible for protecting participants [7][9]. The agency educates, prescreens and refers; the site decides eligibility and obtains consent.
Sources
- WCG Clinical. 2024 Clinical Research Site Challenges Report. WCG Clinical, 2024. Link
- Applequist J, et al. Direct-to-Consumer Recruitment Methods via Traditional and Social Media to Aid in Research Accrual for Clinical Trials for Rare Diseases: Comparative Analysis Study. Journal of Medical Internet Research, 2023. Link
- IntuitionLabs. Clinical Trial Patient Recruitment Vendors Compared. IntuitionLabs, 2026 (a consultancy comparison; directional). Link
- Halpern SD, et al. Effectiveness and Ethics of Incentives for Research Participation: 2 Randomized Clinical Trials. JAMA Internal Medicine, 2021. Link
- ACRP. Progress Seen in Streamlining of Patient Recruitment and Retention for Trials (reporting Tufts CSDD data). ACRP, 2020. Link
- CASRAI. Clinical Trial Recruitment Companies (industry guide). CASRAI, 2026. Link
- International Council for Harmonisation. ICH E6(R3) Good Clinical Practice, Step 4. ICH, 2025. Link
- US Federal Trade Commission. Job Scams. FTC Consumer Advice, 2023. Link
- US Food and Drug Administration. Informed Consent: Guidance for IRBs, Clinical Investigators, and Sponsors. FDA, 2023. Link
- US Food and Drug Administration. Recruiting Study Subjects (Information Sheet). FDA, 1998. Link
- US Food and Drug Administration. Payment and Reimbursement to Research Subjects. FDA, 2018. Link
- Drug Information Association. Participant Compensation. DIA, 2025. Link
More from Refero
